SCHEMBL19953471

SCHEMBL19953471

COC(=O)c1ccc(OC)c(F)c1Cl

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.45
HPGD P15428 4/20 0.44
ALDH1A1 P00352 3/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
ABL1 P00519 1/20 0.44
KMT2A Q03164 4/20 0.42
MEN1 O00255 3/20 0.42
GLA P06280 1/20 0.42
KDM4E B2RXH2 3/20 0.42
LMNA P02545 3/20 0.41
NPC1 O15118 2/20 0.40
MAPT P10636 2/20 0.40
RAB9A P51151 2/20 0.40
SCN8A Q9UQD0 1/20 0.40
SCN10A Q9Y5Y9 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
PDK1 Q15118 1/20 0.40
PDK2 Q15119 1/20 0.40
PDK3 Q15120 1/20 0.40
PDK4 Q16654 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27189680 0.84 SMN1; SMN2 (0.40) HPGDALDH1A1SMN1; SMN2KMT2AMEN1
SCHEMBL4463232 0.84 KDM4E (0.46) GAAHPGDALDH1A1SMN1; SMN2KMT2A
SCHEMBL29665109 0.82 ABL1 (0.46) GAAHPGDALDH1A1SMN1; SMN2ABL1
SCHEMBL27433079 0.81 MYC (0.44) GAAHPGDALDH1A1SMN1; SMN2KMT2A
SCHEMBL8135257 0.81 GAA (0.46) GAAHPGDALDH1A1SMN1; SMN2ABL1
SCHEMBL23537740 0.79 ABL1 (0.56) GAAHPGDALDH1A1SMN1; SMN2ABL1
SCHEMBL23834841 0.79 KDM4E (0.42) GAAHPGDALDH1A1SMN1; SMN2KMT2A
SCHEMBL523584 0.79 ABL1 (0.57) GAAHPGDALDH1A1SMN1; SMN2ABL1
SCHEMBL14747755 0.78 KDM4E (0.41) GAAHPGDALDH1A1SMN1; SMN2KMT2A
SCHEMBL23169066 0.78 ABL1 (0.42) GAAHPGDALDH1A1SMN1; SMN2ABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018046684-A1 PROCESS FOR THE PREPARATION OF SUBSTITUTED 5-{[2-(ALKOXYMETHYL)-3,3,3-TRIFLUORO-2-HYDROXY-1-PHENYLPROPYL]AMINO}QUINOLIN-2(1H)-ONES BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2018-03-15 WO disclosed
WO-2018046684-A1 PROCESS FOR THE PREPARATION OF SUBSTITUTED 5-{[2-(ALKOXYMETHYL)-3,3,3-TRIFLUORO-2-HYDROXY-1-PHENYLPROPYL]AMINO}QUINOLIN-2(1H)-ONES BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2018-03-15 WO disclosed